RPGLIFE vs VENUSREM: Stock Comparison

RPG LIFE SCIENCES vs VENUSREMUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

RPG LIFE SCIENCES is the larger company by market capitalisation. RPG LIFE SCIENCES shows a higher ROE, a higher dividend yield and a higher ROCE, while VENUSREM shows a lower P/E, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

RPGLIFE leads 6; VENUSREM leads 7 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

RPGLIFEVENUSREM

Valuation lens

What price are you paying?

Market CapContext only
₹4,515 Cr
₹2,279 Cr
P/E RatioVENUSREM has the lower reading
51.42x
18.81x
P/B RatioVENUSREM has the lower reading
7.03x
3.29x
EPSVENUSREM has the higher reading
₹18.6
₹19.1
Book ValueContext only
₹366.03
₹496.56
Dividend YieldRPGLIFE has the higher reading
0.91%
0.6%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
RPGLIFE is the larger company
₹4,515 Cr vs ₹2,279 Cr
P/E Ratio
VENUSREM has a lower P/E
18.81x vs 51.42x
P/B Ratio
VENUSREM has a lower P/B
3.29x vs 7.03x
EPS
VENUSREM has higher earnings per share
₹19.1 vs ₹18.6
Dividend Yield
RPGLIFE has a higher dividend yield
0.91% vs 0.6%
Revenue Growth (TTM YoY)
VENUSREM has faster revenue growth
33% vs 23.6%
EPS Growth (TTM YoY)
VENUSREM has faster EPS growth
126.4% vs -74.5%
Qtr Sales Growth
RPGLIFE has stronger quarterly sales growth
0% vs -0.03%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricRPGLIFEVENUSREM
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricRPGLIFEVENUSREM
Live Price₹2,721.6₹1,797.5
Day Change2.61%4.8%
Volume20,4632.46 L
52-Week High₹3,082₹1,800.8
52-Week Low₹1,733₹424
Distance from 52W High-11.69%-0.18%

Valuation

MetricRPGLIFEVENUSREM
Market Cap₹4,515 Cr₹2,279 Cr
P/E Ratio51.42x18.81x
P/B Ratio7.03x3.29x
EPS₹18.6₹19.1
Book Value₹366.03₹496.56
Dividend Yield0.91%0.6%

Growth

MetricRPGLIFEVENUSREM
Revenue Growth (TTM YoY)23.6%33%
EPS Growth (TTM YoY)-74.5%126.4%
Qtr Sales Growth0%-0.03%
Qtr Profit Growth0.62%11.14%

Profitability & Leverage

MetricRPGLIFEVENUSREM
ROE19.02%15.48%
ROCE24.39%16.1%
Net Margin29.25%13.35%
Operating Margin21.92%17.44%
Debt to Equity0.03x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricRPGLIFEVENUSREM
Promoter Holding72.95%41.76%
FII Holding0.95% 0.08 pp2.92% 0.12 pp
DII Holding8.67% 1.22 pp0.89% 0.31 pp
Public Holding17.42% 1.31 pp54.43% 0.19 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: RPG LIFE SCIENCES and VENUSREM.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.